shutterstock_1891094320_guteksk7
guteksk7 / Shutterstock.com
14 October 2021Big PharmaAlex Baldwin

Dems pressure Biden to share Moderna vaccine tech

A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

The lawmaker’s claim that a contract Moderna signed with the US may give it the authority to share “all key information needed to produce the vaccine”.

They also say that Moderna’s refusal to share the technology will delay the vaccination of millions in low and middle-income countries as facilities will be “forced” to spend time replicating existing mRNA technology.

“Despite receiving huge sums of public funding from American taxpayers, Moderna has refused calls to share its technology, including from the US government,” the letter said.

Moderna’s deal

The letter cites a contract Moderna entered into with the Biomedical Advanced Research and Development Authority (BARDA) in April 2020 which may give the federal government the authority to access and share the ingredient list and manufacturing instructions for their COVID vaccine.

The contract gives BARDA “unlimited rights to data funded under this contract” pursuant to a Federal Acquisition Regulations (FAR) clause which defines “data” as “recorded information, regardless of form or the media on which it may be recorded”.

This wording is broad enough to include “all key information needed to produce the vaccine”, the letter claims.

The letter concludes asking the government to publicly clarify what information is covered by the BARDA contract provisions, answer whether it is in discussion with the World Health Organization’s (WHO) mRNA hub project, and clarify any other efforts the administration has made to provide Moderna vaccines to low and middle-income countries.

Biden’s commitments

While the lawmakers praised President Biden’s efforts—including a recent commitment to donate 500 million doses of the Pfizer vaccine to low and middle-income countries—they remain concerned about disparities in vaccine supply.

“It is imperative for the administration to take bold steps to dramatically expand global vaccine access and manufacturing capabilities as quickly as possible,” said the group.

They also called upon the government to pressure remaining WTO member countries to reach an agreement on the South Africa COVID-19 waiver  proposal.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.


More on this story

Big Pharma
12 October 2020   Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.
Big Pharma
23 December 2021   Oxfam America has filed a complaint with the US Securities and Exchange Commission (SEC) claiming that Moderna failed to inform investors that it was in a dispute with the National Institutes of Health over a COVID–19 vaccine patent.
Americas
22 February 2022   US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).

More on this story

Big Pharma
12 October 2020   Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.
Big Pharma
23 December 2021   Oxfam America has filed a complaint with the US Securities and Exchange Commission (SEC) claiming that Moderna failed to inform investors that it was in a dispute with the National Institutes of Health over a COVID–19 vaccine patent.
Americas
22 February 2022   US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).